Site Sponsors
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
Posted in | Nanoanalysis

Report Discusses Flow Cytometry Markets in France, Germany, Italy, Spain and UK

Published on April 4, 2012 at 2:18 AM

By Cameron Chai

Research and Markets has included a new report titled ‘The 2012 European Flow Cytometry Market: France, Germany, Italy, Spain, UK’ to its catalogue.

This comprehensive report on the European flow cytometry market provides data pertaining to test volume forecasts, order placements for instruments, installed base in terms of models and producers, and market shares of major reagent and instrument suppliers.

The report discusses future technological and marketing trends of the flow cytometry industry in the United Kingdom, Spain, Italy, Germany and France. The five-country report will be helpful to potential market entrants and existing suppliers to detect and assess the prospects in the European flow cytometry market in the next five years. It provides feature comparison data of major research and clinical flow cytometers and suggests exclusive opportunities for flow cytometry reagents and instruments.

According to the report, ongoing developments in information technology, lasers, monoclonal antibodies and molecular diagnostics, as well as expanding awareness of immunologic forces that control systemic diseases, will affect the global flow cytometry market in the next five years. Latest monoclonal antibody and molecular diagnostic tests will simplify existing procedures and offer simple, specific and sensitive assays.

The launch of tiny and user-friendly laser systems will further extend the use of flow cytometry in custom clinical laboratories. Continued advances in information technology will decrease the cost of instrument production, service warranty; develop auto-calibration, self-troubleshooting and other sophisticated features; and automate and customize current tedious analyses of lymphocyte subsets, DNA content and chromosomal abnormalities.

Companies profiled in the report include Sysmex, Siemens, Roche, Ortho-Clinical Diagnostics, Nihon Kohden, Iris, Horiba, Dako, Bio-Rad, Becton Dickinson, Danaher, Beckman Coulter and Abbott.

Source: http://www.researchandmarkets.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit